Chronic DOCA treatment increases Ca absorption: role of hypercalciuria and vitamin D.
To examine the effects of mineralocorticoidism on calcium (Ca) absorption and to define the mechanism, rats received a high-salt diet and injections of vehicle or deoxycorticosterone acetate (DOCA). Net (44.2 vs. 31.4 mg/day) and percent Ca absorption (28.1 vs. 20.1%) was increased after 5 days of DOCA. This was associated with increased duodenal 45Ca uptake. Thus despite the hypercalciuria, Ca balance was similar. Although the hypercalciuria persisted chronically, the gut effects were sustained, which maintained normal ionized Ca, bone Ca, and Ca balance. Urinary cyclic adenosine monophosphate was elevated by DOCA. Compared with appropriate controls, neither DOCA alone nor polydipsia (elicited by dextrose) produced similar magnitudes of hypercalciuria as DOCA plus high-salt diet. These maneuvers also failed to increase Ca absorption. Neutralization of the metabolic alkalosis neither attenuated the DOCA-induced hypercalciuria nor abolished the Ca hyperabsorption. In vitamin D-deprived rats, the hypercalciuria but not the intestinal effects of DOCA were reproduced. Serum 1,25-dihydroxyvitamin D3 levels were increased during chronic DOCA treatment (224 vs. 139 pg/ml). These data best fit the hypothesis that increased Ca absorption is secondary to the calciuric effects of DOCA and high-salt diet and is mediated via the increased parathyroid hormone and 1,25-dihydroxyvitamin D3 activities.
D000471:Alkalosis / Q000139:chemically induced / Q000378:metabolism; D000818:Animals; D002117:Calcitriol / Q000502:physiology*; D002118:Calcium / Q000378:metabolism / Q000652:urine*; D000242:Cyclic AMP / Q000652:urine; D003900:Desoxycorticosterone / Q000494:pharmacology* / Q000633:toxicity; D004326:Drinking; D007408:Intestinal Absorption / Q000187:drug effects*; D051381:Rats
D003900:Desoxycorticosterone; D000242:Cyclic AMP; D002117:Calcitriol; D002118:Calcium